PHOTIC REGULATION OF CIRCADIAN RHYTHMS
昼夜节律的光调节
基本信息
- 批准号:6226862
- 负责人:
- 金额:$ 29.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-12-15 至 2004-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Applicant's Description): Society's reluctance to accept the
importance of our body's circadian clock has resulted in maladies ranging from
jet lag to tragic, fatigue-induced commercial accidents. Administration of
drugs with no regard to the time of day can result in widely variable drug
efficacy and capricious tolerance of side effects. Several psychiatric and
sleep disorders have been attributed to a dysfunctional circadian system. A
better understanding of how the circadian clock is regulated and synchronized
to the environment will lead to phototherapeutic and pharmacologic strategies
to address these "chronopathologies." Light detected through the eyes is the
primary agent responsible for synchronizing the mammalian circadian clock to
the environment. Paradoxically, the only known photoreceptors in retina (the
rods and cones) are not required for this synchronizing effect of light.
Animals lacking rods and cones continue to regulate their circadian systems
normally. These data suggest that a non-rod, non-cone class of photoreceptor
must exist within the mammalian eye. We have identified a novel human and mouse
opsin, melanopsin, that is similar to the rod and cone opsin photopigments.
Melanopsin is not localized to rods or cones, but rather to very few cells
within the ganglion cell layer of the mouse inner retina. Interestingly, this
unique distribution is identical to the distribution of ganglion cells known to
project to the hypothalamic suprachiasmatic nuclei (SCN), the central circadian
oscillator of mammals. These melanopsin-containing cells are the best candidate
circadian photoreceptors known to date.
The central hypothesis of this application is that melanopsin is required for
normal photic regulation of circadian rhythms in mammals. To test this
hypothesis, we will determine the spectral absorption profile of heterologously
expressed mouse melanopsin to see if it matches the known spectral sensitivity
of the murine circadian system. We will determine if melanopsin is localized in
ganglion cells labeled by retrograde neuronal tract tracers originating in the
SCN. Finally, we will assay the circadian photosensitivity of mice lacking
functional melanopsin. Successful completion of these aims will give us a
better understanding of melanopsin's role in the photoregulation of circadian
rhythms. Confirmation of melanopsin's involvement in circadian rhythm
regulation will provide a therapeutic "entry point" for the treatment of
circadian disorders.
描述(申请人的描述):社会不愿意接受
我们身体生物钟的重要性导致了各种疾病,
从时差到疲劳导致的悲惨商业事故。总局
不考虑一天中的时间的药物可能导致广泛的药物变化,
疗效和对副作用的耐受性。一些精神病和
睡眠障碍归因于生理节律系统功能失调。一
更好地了解生物钟是如何调节和同步的
将导致光疗和药理学策略
来解决这些"时间病理学" "通过眼睛检测到的光是
负责同步哺乳动物生物钟的主要代理人,
环境保护奇怪的是,视网膜中唯一已知的光感受器(
视杆细胞和视锥细胞)对于这种光的同步效应是不需要的。
缺少视杆细胞和视锥细胞的动物继续调节它们的昼夜节律系统
正常情况下这些数据表明,非杆,非锥类感光细胞
必须存在于哺乳动物的眼睛里我们发现了一种新的人类和老鼠
视蛋白,黑视蛋白,即类似视杆和视锥的视蛋白色素。
黑视蛋白不局限于视杆细胞或视锥细胞,而是局限于极少数细胞
在小鼠视网膜内层的神经节细胞层内。有趣的是,
独特的分布与已知的神经节细胞的分布相同,
投射到下丘脑视交叉上核(SCN),中枢昼夜节律
哺乳动物的振荡器这些含有黑视蛋白的细胞是最好的候选者
迄今已知的昼夜光感受器。
本申请的中心假设是黑视素是用于
哺乳动物昼夜节律的正常光调节。为了验证这一
假设,我们将确定异相的光谱吸收曲线,
表达的小鼠黑视蛋白,看看它是否符合已知的光谱灵敏度
的生理节律系统。我们将确定黑视素是否位于
神经节细胞标记的逆行神经束示踪剂起源于
SCN。最后,我们将分析缺乏光敏感性的小鼠的昼夜光敏感性。
功能性黑视蛋白成功地完成这些目标将使我们
更好地理解黑视素在昼夜节律光调节中的作用
节奏证实黑视素参与昼夜节律
监管将提供一个治疗"切入点",
昼夜节律紊乱
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IGNACIO PROVENCIO其他文献
IGNACIO PROVENCIO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IGNACIO PROVENCIO', 18)}}的其他基金
Biennial Meeting Society for Research on Biological Rhythms
生物节律研究协会每两年一次的会议
- 批准号:
7916255 - 财政年份:2010
- 资助金额:
$ 29.64万 - 项目类别:
In vivo Studies of Vertebrate Circadian Clock Genes
脊椎动物昼夜节律时钟基因的体内研究
- 批准号:
7458609 - 财政年份:2000
- 资助金额:
$ 29.64万 - 项目类别:
相似海外基金
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
- 批准号:
10611521 - 财政年份:2022
- 资助金额:
$ 29.64万 - 项目类别:
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
- 批准号:
10467737 - 财政年份:2022
- 资助金额:
$ 29.64万 - 项目类别:
Basic research on nucleic acids therapeutics for IL-12p40 gene targeting
IL-12p40基因靶向核酸治疗的基础研究
- 批准号:
20K16082 - 财政年份:2020
- 资助金额:
$ 29.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A new bladder cancer model based on tissue reprogramming and gene targeting
基于组织重编程和基因靶向的新膀胱癌模型
- 批准号:
10084281 - 财政年份:2020
- 资助金额:
$ 29.64万 - 项目类别:
A new bladder cancer model based on tissue reprogramming and gene targeting
基于组织重编程和基因靶向的新膀胱癌模型
- 批准号:
9896122 - 财政年份:2020
- 资助金额:
$ 29.64万 - 项目类别:
Multiplex gene targeting with CRISPR/Cas9 using single guide RNAs
使用单引导 RNA 通过 CRISPR/Cas9 进行多重基因打靶
- 批准号:
540963-2019 - 财政年份:2019
- 资助金额:
$ 29.64万 - 项目类别:
University Undergraduate Student Research Awards
Development of conditional and inducible gene targeting tools in rabbits
兔子条件性和诱导性基因打靶工具的开发
- 批准号:
9317588 - 财政年份:2017
- 资助金额:
$ 29.64万 - 项目类别:
Core B: Transgenic and Gene-Targeting Institutional Facility
核心 B:转基因和基因靶向机构设施
- 批准号:
10215556 - 财政年份:2017
- 资助金额:
$ 29.64万 - 项目类别:
Exploring function of mu opioid receptor splice variants in rat by gene targeting
通过基因打靶探索大鼠μ阿片受体剪接变体的功能
- 批准号:
9312277 - 财政年份:2016
- 资助金额:
$ 29.64万 - 项目类别:
Mechanistic Study and Gene Targeting to Block HIV Assembly by IN-Binding Protein
通过 IN 结合蛋白阻断 HIV 组装的机制研究和基因靶向
- 批准号:
9377499 - 财政年份:2016
- 资助金额:
$ 29.64万 - 项目类别: